Glycologix Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $800K

  • Investors
  • 4

Glycologix General Information

Description

Developer of a clinical-stage biotechnology platform designed for soft tissue protection and repair. The company's lead asset is a cross-linked biopolymer delivered as a periodic bladder instillation that restores the urothelial protective layer with high tissue affinity and extended residence time, enabling healthcare professionals to address unmet medical needs in protecting and repairing soft tissues.

Contact Information

Website
www.glycologix.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 100 Cummings Center
  • Suite 451C
  • Beverly, MA 01915
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • 100 Cummings Center
  • Suite 451C
  • Beverly, MA 01915
  • United States
+1 (617)

Glycologix Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glycologix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 29-Dec-2025 $800K Completed Clinical Trials - Phase 1
6. Seed Round 05-Apr-2024 Completed Clinical Trials - Phase 1
5. Seed Round 15-May-2023 Completed Pre-Clinical Trials
4. Seed Round 31-Mar-2022 Completed Pre-Clinical Trials
3. Grant 29-Jun-2020 Completed Generating Revenue
2. Accelerator/Incubator 01-Jun-2018 Completed Generating Revenue
1. Grant 01-May-2018 $288K Completed Generating Revenue
To view Glycologix’s complete valuation and funding history, request access »

Glycologix Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed III
Seed II
Seed I 3,300,000 $0.000100 $0.07 $1.24 $1.24 1x $1.24 27.9%
To view Glycologix’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Glycologix Patents

  • 24

    Total Documents Applications and Grants

  • Total Patents Families

  • 15

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

Glycologix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021237704-A1 Sulfated glycosaminoglycan biomaterials as proteoglycan mimics Active 19-Mar-2020
AU-2021237704-B2 Sulfated glycosaminoglycan biomaterials as proteoglycan mimics Active 19-Mar-2020
CA-3171629-A1 Sulfated glycosaminoglycan biomaterials as proteoglycan mimics Active 19-Mar-2020
EP-4121064-A1 Sulfated glycosaminoglycan biomaterials as proteoglycan mimics Pending 19-Mar-2020
EP-4121064-A4 Sulfated glycosaminoglycan biomaterials as proteoglycan mimics Pending 19-Mar-2020 C08B37/0063
To view Glycologix’s complete patent history, request access »

Glycologix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Glycologix Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cortado Ventures Venture Capital Minority
eCoast Angels Angel Group Minority
InnoVentures Lab Accelerator/Incubator Minority
National Institute of Diabetes and Digestive and Kidney Diseases Government
To view Glycologix’s complete investors history, request access »

Ready to get started?

Request a free trial

Glycologix FAQs

  • When was Glycologix founded?

    Glycologix was founded in 2016.

  • Where is Glycologix headquartered?

    Glycologix is headquartered in Beverly, MA.

  • What is the size of Glycologix?

    Glycologix has 8 total employees.

  • What industry is Glycologix in?

    Glycologix’s primary industry is Drug Discovery.

  • Is Glycologix a private or public company?

    Glycologix is a Private company.

  • What is Glycologix’s current revenue?

    The current revenue for Glycologix is .

  • How much funding has Glycologix raised over time?

    Glycologix has raised $7.45M.

  • Who are Glycologix’s investors?

    Cortado Ventures, eCoast Angels, InnoVentures Lab, and National Institute of Diabetes and Digestive and Kidney Diseases have invested in Glycologix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process